FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

44148011000036106: Clarinase Repetab (loratadine 5 mg + pseudoephedrine sulfate 120 mg) modified release tablet, 18 tablets, blister pack (containered trade product pack)


Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
979798401000036111 Clarinase Repetab modified release tablet, 18, blister pack en Synonym Active Case sensitive Australian Medicines Terminology module
979798411000036113 Clarinase Repetab (loratadine 5 mg + pseudoephedrine sulfate 120 mg) modified release tablet, 18 tablets, blister pack (containered trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Clarinase Repetab modified release tablet, 18, blister pack Is a containered trade product pack true Inferred relationship Some
Clarinase Repetab modified release tablet, 18, blister pack Is a Clarinase Repetab modified release tablet, 18 true Inferred relationship Some
Clarinase Repetab modified release tablet, 18, blister pack has container type blister pack true Inferred relationship Some
Clarinase Repetab modified release tablet, 18, blister pack has TPUU Clarinase Repetab modified release tablet true Inferred relationship Some 1
Clarinase Repetab modified release tablet, 18, blister pack has TP Clarinase Repetab true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)

Containered trade product pack reference set

Back to Start